Autologous stem cell and Non-stem cell based Therapies Market Size by Product, Type, Application, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029
14.2%
CAGR (2023-2029)
4.27 USD Bn.
Market Size
301
Report Pages
153
Market Tables
Overview
Autologous Stem Cell and Non-stem Cell Based Therapies Market size is expected to reach nearly US$ 10.82 Bn. by 2029 with the CAGR of 14.2% during the forecast period.
Autologous stem cell and Non-stem cell based Therapies Market Overview
Regenerative medicine is now a global venture. Fresh ideas, advanced technologies and an increasing need, continue to revitalize and strengthen the interest of investors in this market. Autologous Stem cell Therapy is changing medical treatments by introducing new therapies. The market has a vast scope and a promising future over standard therapies. Autologous stem cell and non-autologous stem cell based therapies are considered to be safer and effective in comparison with other transplant therapies. Autologous transplants reduce the risks of disease transmission, bio-incompatibility and immunological reactions.
To know about the Research Methodology :- Request Free Sample Report
Healthcare regulatory bodies are expecting companies to develop therapy treatments that are safer, affordable and easy to use. Autologous Stem cell transplantation therapy is safe to use, has minimum number of steps to follow and is rapid in delivering results. These characteristics of the therapy are helping the market growth. The sources for ACT are mesenchymal stem cells, haematopoietic stem cells and chondrocytes. ACT has been successful in treatment of cancer, cosmetic surgeries, skin burns etc. Hence, this technology is expected to provide huge opportunities for investors and manufacturers in the global market. However, the current cost for this therapy is not affordable and is a major restraint for the market.
The report provides a detailed analysis about the autologous and non-autologous stem cell based therapies market. It includes the recent advances, applications and ongoing trends globally. Funding for treatments, partnerships between key players, revenue forecasts of companies are also provided in detail in the report. The report also provides information on application areas to help investors invest rightly.
The report has profiled twenty three key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
Autologous stem cell and Non-stem cell based Therapies Market Segment Analysis
Cancer holds a significant share in the Autologous and Non-autologous stem cell based therapies market The increasing prevalence of cancer globally is a major concern. According to WHO, cancer was responsible for about 9.6 million deaths globally in 2022. Approximately 70% of deaths from cancer occur in low and middle-income countries. The most common causes of cancer death are lung cancer, stomach cancer, colorectal cancer etc.
Autologous stem cell transplant’s goal is to restore the body’s ability to make normal blood cells after doses of radiation or chemotherapy. The Autologous transplantation therapy uses the “Engraftment” technique and is quicker than an allogeneic transplant. The market for ACT and non-ACT based therapies is expected to grow at a CAGR of xx% during the forecast period, owing to its wide range applications and promising results.
Increasing hypertension globally leads to an increase in demand for home monitoring devices
The blood pressure monitoring devices of product segment are expected to gain momentum in the forecast period, thereby driving the market for ACT and non-ACT based therapies. Advancements in mobile based BP monitoring systems, wearable and portable devices are gaining popularity and are positively impacting the market growth. Benefit of automated devices such as repetitive measurements of BP with accuracy is contributing to market growth. These devices are available in various forms, including arm, wrist and finger for measurement of blood pressure.
Regional Insights
North America dominates the Autologous Stem cells and Non-Autologous stem cell based therapies market.
North America dominated the stem cell market contributing to the largest share of xx% in the market. The availability of funds from various organizations and presence of key players in the region is encouraging investors to invest more. Various stem cell studies across the US are helping the market to accelerate.
In SA and NA, treatments through ACT and non-ACT based therapies for diabetes and other diseases are actively progressing. European countries are also actively engaged in the development of ACT and non-ACT based therapies. In developing nations of the APAC region large investments are being made for stem cell therapies, which is expected to drive the market growth.
Autologous stem cell and Non-stem cell based Therapies Market Scope : Inquire before buying
| Autologous stem cell and Non-stem cell based Therapies Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2018 to 2022 | Market Size in 2022: | US $ 4.27 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 14.2% | Market Size in 2029: | US $ 10.82 Bn. |
| Segments Covered: | by Product | Neurodegenerative disorders Autoimmune diseases Cancer and Tumours Cardiovascular Diseases |
|
| by Type | Blood Pressure monitoring devices Pulmonary pressure monitoring devices Intracranial pressure monitoring devices |
||
| by Application | Hospitals Ambulatory surgical centers Others |
||
Key Players:
1. Fibrocell Science, Inc
2. Astrom Biosciences
3. Dendreon Corporation
4. NeoStem, Inc
5. Brainstorm Cell therapeutics
6. Regeneus Ltd
7. Genzyme Corporation
8. Antria
9. Bioheart
10. Cytori Therapeutics
11. Genesis Biopharma
12. Opexa Therapeutics
13. Orgenesis
14. Regenexx
15. Tengion
16. Sanofi
17. Mesoblast Ltd
18. Virxsys
19. StemGeneXamong
20. Vericel Corporation
21. Med Cell Europe AG
22. IovanceBiotherapeutics Inc
Frequently Asked Questions:
1. Which region has the largest share in Global Autologous stem cell and non-autologous stem cell Market?
Ans: North America region holds the highest share in 2022.
2. What is the growth rate of Global Autologous stem cell and non-autologous stem cell Market?
Ans: The Global Autologous stem cell and non-autologous stem cell Market is growing at a CAGR of 14.2% during forecasting period 2023-2029.
3. What is scope of the Global Autologous stem cell and non-autologous stem cell market report?
Ans: Global Autologous stem cell and non-autologous stem cell Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Autologous stem cell and non-autologous stem cell market?
Ans: The important key players in the Global Autologous stem cell and non-autologous stem cell Market are – Fibrocell Science, Inc, Astrom Biosciences, Dendreon Corporation, NeoStem, Inc, Brainstorm Cell therapeutics, Regeneus Ltd, Genzyme Corporation,
5. What is the study period of this market?
Ans: The Global Autologous stem cell and non-autologous stem cell Market is studied from 2022 to 2029.
Table of Contents
Global Autologous stem cell and Non-stem cell based Therapies Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: GOLBAL AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size, By Market Value (US$ Mn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis and Forecast
6.1. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis and Forecast, By Applications
7.1. Introduction and Definition
7.2. Key Findings
7.3. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications
7.4. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size (US$ Mn) Forecast, By Applications
7.5. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Applications
7.6. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis, By Applications
8. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis and Forecast, By Products
8.1. Introduction and Definition
8.2. Key Findings
8.3. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products
8.4. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size (US$ Mn) Forecast, By Products
8.5. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Products
8.6. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis, By Products
9. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis and Forecast By End-users
9.1. Introduction and Definition
9.2. Key Findings
9.3. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users
9.4. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size (US$ Mn) Forecast, By End-users
9.5. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By End-users
9.6. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis, By End-users
10. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Region
10.1. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Region
10.2. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size (US$ Mn) Forecast, By Region
10.3. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis, By Region
11. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis
11.1. Key Findings
11.2. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview
11.3. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications
11.4. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
11.4.1. Neurodegenerative disorders
11.4.2. Autoimmune diseases
11.4.3. Cancer and Tumors
11.4.4. Cardiovascular Diseases
11.5. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products
11.6. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
11.6.1. Blood Pressure monitoring devices
11.6.2. Pulmonary pressure monitoring devices
11.6.3. Intracranial pressure monitoring devices
11.7. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users
11.8. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
11.8.1. Hospitals
11.8.2. Ambulatory surgical centers
11.8.3. Others
11.9. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country
11.10. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country
11.10.1. U.S.
11.10.2. Canada
11.10.3. Mexico
11.11. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Country
11.12. U.S. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
11.12.1. Neurodegenerative disorders
11.12.2. Autoimmune diseases
11.12.3. Cancer and Tumors
11.12.4. Cardiovascular Diseases
11.13. U.S. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
11.13.1. Blood Pressure monitoring devices
11.13.2. Pulmonary pressure monitoring devices
11.13.3. Intracranial pressure monitoring devices
11.14. U.S. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
11.14.1. Hospitals
11.14.2. Ambulatory surgical centers
11.14.3. Others
11.15. Canada AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
11.15.1. Neurodegenerative disorders
11.15.2. Autoimmune diseases
11.15.3. Cancer and Tumors
11.15.4. Cardiovascular Diseases
11.16. Canada AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
11.16.1. Blood Pressure monitoring devices
11.16.2. Pulmonary pressure monitoring devices
11.16.3. Intracranial pressure monitoring devices
11.17. Canada AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
11.17.1. Hospitals
11.17.2. Ambulatory surgical centers
11.17.3. Others
11.18. Mexico AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
11.18.1. Neurodegenerative disorders
11.18.2. Autoimmune diseases
11.18.3. Cancer and Tumors
11.18.4. Cardiovascular Diseases
11.19. Mexico AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
11.19.1. Blood Pressure monitoring devices
11.19.2. Pulmonary pressure monitoring devices
11.19.3. Intracranial pressure monitoring devices
11.20. Mexico AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
11.20.1. Hospitals
11.20.2. Ambulatory surgical centers
11.20.3. Others
11.21. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis
11.21.1. By Applications
11.21.2. By Products
11.21.3. By End-users
11.22. PEST Analysis
11.23. Key Trends
11.24. Key Developments
12. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis
12.1. Key Findings
12.2. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview
12.3. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications
12.4. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.4.1. Neurodegenerative disorders
12.4.2. Autoimmune diseases
12.4.3. Cancer and Tumors
12.4.4. Cardiovascular Diseases
12.5. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products
12.6. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.6.1. Blood Pressure monitoring devices
12.6.2. Pulmonary pressure monitoring devices
12.6.3. Intracranial pressure monitoring devices
12.7. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users
12.8. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.8.1. Hospitals
12.8.2. Ambulatory surgical centers
12.8.3. Others
12.9. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country
12.10. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Sweden
12.10.7. CIS countries
12.10.8. Rest of Europe
12.11. Germany AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.11.1. Neurodegenerative disorders
12.11.2. Autoimmune diseases
12.11.3. Cancer and Tumors
12.11.4. Cardiovascular Diseases
12.12. Germany AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.12.1. Blood Pressure monitoring devices
12.12.2. Pulmonary pressure monitoring devices
12.12.3. Intracranial pressure monitoring devices
12.13. Germany AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.13.1. Hospitals
12.13.2. Ambulatory surgical centers
12.13.3. Others
12.14. U.K. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.14.1. Neurodegenerative disorders
12.14.2. Autoimmune diseases
12.14.3. Cancer and Tumors
12.14.4. Cardiovascular Diseases
12.15. U.K. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.15.1. Blood Pressure monitoring devices
12.15.2. Pulmonary pressure monitoring devices
12.15.3. Intracranial pressure monitoring devices
12.16. U.K. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.16.1. Hospitals
12.16.2. Ambulatory surgical centers
12.16.3. Others
12.17. France AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.17.1. Neurodegenerative disorders
12.17.2. Autoimmune diseases
12.17.3. Cancer and Tumors
12.17.4. Cardiovascular Diseases
12.18. France AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.18.1. Blood Pressure monitoring devices
12.18.2. Pulmonary pressure monitoring devices
12.18.3. Intracranial pressure monitoring devices
12.19. France AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.19.1. Hospitals
12.19.2. Ambulatory surgical centers
12.19.3. Others
12.20. Italy AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.20.1. Neurodegenerative disorders
12.20.2. Autoimmune diseases
12.20.3. Cancer and Tumors
12.20.4. Cardiovascular Diseases
12.21. Italy AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.21.1. Blood Pressure monitoring devices
12.21.2. Pulmonary pressure monitoring devices
12.21.3. Intracranial pressure monitoring devices
12.22. Italy AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.22.1. Hospitals
12.22.2. Ambulatory surgical centers
12.22.3. Others
12.23. Spain AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.23.1. Neurodegenerative disorders
12.23.2. Autoimmune diseases
12.23.3. Cancer and Tumors
12.23.4. Cardiovascular Diseases
12.24. Spain AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.24.1. Blood Pressure monitoring devices
12.24.2. Pulmonary pressure monitoring devices
12.24.3. Intracranial pressure monitoring devices
12.25. Spain AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.25.1. Hospitals
12.25.2. Ambulatory surgical centers
12.25.3. Others
12.26. Sweden AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.26.1. Neurodegenerative disorders
12.26.2. Autoimmune diseases
12.26.3. Cancer and Tumors
12.26.4. Cardiovascular Diseases
12.27. Sweden AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.27.1. Blood Pressure monitoring devices
12.27.2. Pulmonary pressure monitoring devices
12.27.3. Intracranial pressure monitoring devices
12.28. Sweden AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.28.1. Hospitals
12.28.2. Ambulatory surgical centers
12.28.3. Others
12.29. CIS countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.29.1. Neurodegenerative disorders
12.29.2. Autoimmune diseases
12.29.3. Cancer and Tumors
12.29.4. Cardiovascular Diseases
12.30. CIS countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.30.1. Blood Pressure monitoring devices
12.30.2. Pulmonary pressure monitoring devices
12.30.3. Intracranial pressure monitoring devices
12.31. CIS countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.31.1. Hospitals
12.31.2. Ambulatory surgical centers
12.31.3. Others
12.32. Rest of Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
12.32.1. Neurodegenerative disorders
12.32.2. Autoimmune diseases
12.32.3. Cancer and Tumors
12.32.4. Cardiovascular Diseases
12.33. Rest of Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
12.33.1. Blood Pressure monitoring devices
12.33.2. Pulmonary pressure monitoring devices
12.33.3. Intracranial pressure monitoring devices
12.34. Rest of Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
12.34.1. Hospitals
12.34.2. Ambulatory surgical centers
12.34.3. Others
12.35. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis
12.35.1. By Products
12.35.2. By Applications
12.35.3. By End-users
12.36. PEST Analysis
12.37. Key Trends
12.38. Key Developments
13. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis
13.1. Key Findings
13.2. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview
13.3. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications
13.4. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
13.4.1. Neurodegenerative disorders
13.4.2. Autoimmune diseases
13.4.3. Cancer and Tumors
13.4.4. Cardiovascular Diseases
13.5. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products
13.6. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
13.6.1. Blood Pressure monitoring devices
13.6.2. Pulmonary pressure monitoring devices
13.6.3. Intracranial pressure monitoring devices
13.7. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users
13.8. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
13.8.1. Hospitals
13.8.2. Ambulatory surgical centers
13.8.3. Others
13.9. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country
13.10. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. South Korea
13.10.5. Australia
13.10.6. ASEAN
13.10.7. Rest of Asia Pacific
13.11. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Country
13.12. China AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
13.12.1. Neurodegenerative disorders
13.12.2. Autoimmune diseases
13.12.3. Cancer and Tumors
13.12.4. Cardiovascular Diseases
13.13. China AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
13.13.1. Blood Pressure monitoring devices
13.13.2. Pulmonary pressure monitoring devices
13.13.3. Intracranial pressure monitoring devices
13.14. China AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
13.14.1. Hospitals
13.14.2. Ambulatory surgical centers
13.14.3. Others
13.15. India AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
13.15.1. Neurodegenerative disorders
13.15.2. Autoimmune diseases
13.15.3. Cancer and Tumors
13.15.4. Cardiovascular Diseases
13.16. India AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
13.16.1. Blood Pressure monitoring devices
13.16.2. Pulmonary pressure monitoring devices
13.16.3. Intracranial pressure monitoring devices
13.17. India AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
13.17.1. Hospitals
13.17.2. Ambulatory surgical centers
13.17.3. Others
13.18. Japan AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
13.18.1. Neurodegenerative disorders
13.18.2. Autoimmune diseases
13.18.3. Cancer and Tumors
13.18.4. Cardiovascular Diseases
13.19. Japan AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
13.19.1. Blood Pressure monitoring devices
13.19.2. Pulmonary pressure monitoring devices
13.19.3. Intracranial pressure monitoring devices
13.20. Japan AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
13.20.1. Hospitals
13.20.2. Ambulatory surgical centers
13.20.3. Others
13.21. South Korea AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
13.21.1. Neurodegenerative disorders
13.21.2. Autoimmune diseases
13.21.3. Cancer and Tumors
13.21.4. Cardiovascular Diseases
13.22. South Korea AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
13.22.1. Blood Pressure monitoring devices
13.22.2. Pulmonary pressure monitoring devices
13.22.3. Intracranial pressure monitoring devices
13.23. South Korea AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
13.23.1. Hospitals
13.23.2. Ambulatory surgical centers
13.23.3. Others
13.24. Australia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
13.24.1. Neurodegenerative disorders
13.24.2. Autoimmune diseases
13.24.3. Cancer and Tumors
13.24.4. Cardiovascular Diseases
13.25. Australia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
13.25.1. Blood Pressure monitoring devices
13.25.2. Pulmonary pressure monitoring devices
13.25.3. Intracranial pressure monitoring devices
13.26. Australia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
13.26.1. Hospitals
13.26.2. Ambulatory surgical centers
13.26.3. Others
13.27. ASEAN AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
13.27.1. Neurodegenerative disorders
13.27.2. Autoimmune diseases
13.27.3. Cancer and Tumors
13.27.4. Cardiovascular Diseases
13.28. ASEAN AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
13.28.1. Blood Pressure monitoring devices
13.28.2. Pulmonary pressure monitoring devices
13.28.3. Intracranial pressure monitoring devices
13.29. ASEAN AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
13.29.1. Hospitals
13.29.2. Ambulatory surgical centers
13.29.3. Others
13.30. Rest of Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
13.30.1. Neurodegenerative disorders
13.30.2. Autoimmune diseases
13.30.3. Cancer and Tumors
13.30.4. Cardiovascular Diseases
13.31. Rest of Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
13.31.1. Blood Pressure monitoring devices
13.31.2. Pulmonary pressure monitoring devices
13.31.3. Intracranial pressure monitoring devices
13.32. Rest of Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
13.32.1. Hospitals
13.32.2. Ambulatory surgical centers
13.32.3. Others
13.33. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis
13.33.1. By Applications
13.33.2. By Products
13.33.3. By End-users
13.34. PEST Analysis
13.35. Key Trends
13.36. Key Developments
14. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis
14.1. Key Findings
14.2. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview
14.3. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications
14.4. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
14.4.1. Neurodegenerative disorders
14.4.2. Autoimmune diseases
14.4.3. Cancer and Tumors
14.4.4. Cardiovascular Diseases
14.5. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products
14.6. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
14.6.1. Blood Pressure monitoring devices
14.6.2. Pulmonary pressure monitoring devices
14.6.3. Intracranial pressure monitoring devices
14.7. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users
14.8. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
14.8.1. Hospitals
14.8.2. Ambulatory surgical centers
14.8.3. Others
14.9. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country
14.10. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country
14.10.1. GCC Countries
14.10.2. South Africa
14.10.3. Nigeria
14.10.4. Egypt
14.10.5. Rest of Middle East & Africa
14.11. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Country
14.12. GCC Countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
14.12.1. Neurodegenerative disorders
14.12.2. Autoimmune diseases
14.12.3. Cancer and Tumors
14.12.4. Cardiovascular Diseases
14.13. GCC Countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
14.13.1. Blood Pressure monitoring devices
14.13.2. Pulmonary pressure monitoring devices
14.13.3. Intracranial pressure monitoring devices
14.14. GCC Countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
14.14.1. Hospitals
14.14.2. Ambulatory surgical centers
14.14.3. Others
14.15. South Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
14.15.1. Neurodegenerative disorders
14.15.2. Autoimmune diseases
14.15.3. Cancer and Tumors
14.15.4. Cardiovascular Diseases
14.16. South Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
14.16.1. Blood Pressure monitoring devices
14.16.2. Pulmonary pressure monitoring devices
14.16.3. Intracranial pressure monitoring devices
14.17. South Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
14.17.1. Hospitals
14.17.2. Ambulatory surgical centers
14.17.3. Others
14.18. Nigeria AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
14.18.1. Neurodegenerative disorders
14.18.2. Autoimmune diseases
14.18.3. Cancer and Tumors
14.18.4. Cardiovascular Diseases
14.19. Nigeria AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
14.19.1. Blood Pressure monitoring devices
14.19.2. Pulmonary pressure monitoring devices
14.19.3. Intracranial pressure monitoring devices
14.20. Nigeria AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
14.20.1. Hospitals
14.20.2. Ambulatory surgical centers
14.20.3. Others
14.21. Egypt AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
14.21.1. Neurodegenerative disorders
14.21.2. Autoimmune diseases
14.21.3. Cancer and Tumors
14.21.4. Cardiovascular Diseases
14.22. Egypt AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
14.22.1. Blood Pressure monitoring devices
14.22.2. Pulmonary pressure monitoring devices
14.22.3. Intracranial pressure monitoring devices
14.23. Egypt AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
14.23.1. Hospitals
14.23.2. Ambulatory surgical centers
14.23.3. Others
14.24. Rest of Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
14.24.1. Neurodegenerative disorders
14.24.2. Autoimmune diseases
14.24.3. Cancer and Tumors
14.24.4. Cardiovascular Diseases
14.25. Rest of Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
14.25.1. Blood Pressure monitoring devices
14.25.2. Pulmonary pressure monitoring devices
14.25.3. Intracranial pressure monitoring devices
14.26. Rest of Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
14.26.1. Hospitals
14.26.2. Ambulatory surgical centers
14.26.3. Others
14.27. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis
14.27.1. By Applications
14.27.2. By Products
14.27.3. By End-users
14.28. PEST Analysis
14.29. Key Trends
14.30. Key Developments
15. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis
15.1. Key Findings
15.2. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview
15.3. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications
15.4. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
15.4.1. Neurodegenerative disorders
15.4.2. Autoimmune diseases
15.4.3. Cancer and Tumors
15.4.4. Cardiovascular Diseases
15.5. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products
15.6. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
15.6.1. Blood Pressure monitoring devices
15.6.2. Pulmonary pressure monitoring devices
15.6.3. Intracranial pressure monitoring devices
15.7. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users
15.8. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
15.8.1. Hospitals
15.8.2. Ambulatory surgical centers
15.8.3. Others
15.9. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country
15.10. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country
15.10.1. Brazil
15.10.2. Colombia
15.10.3. Argentina
15.10.4. Rest of South America
15.11. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Country
15.12. Brazil AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
15.12.1. Neurodegenerative disorders
15.12.2. Autoimmune diseases
15.12.3. Cancer and Tumors
15.12.4. Cardiovascular Diseases
15.13. Brazil AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
15.13.1. Blood Pressure monitoring devices
15.13.2. Pulmonary pressure monitoring devices
15.13.3. Intracranial pressure monitoring devices
15.14. Brazil AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
15.14.1. Hospitals
15.14.2. Ambulatory surgical centers
15.14.3. Others
15.15. Colombia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
15.15.1. Neurodegenerative disorders
15.15.2. Autoimmune diseases
15.15.3. Cancer and Tumors
15.15.4. Cardiovascular Diseases
15.16. Colombia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
15.16.1. Blood Pressure monitoring devices
15.16.2. Pulmonary pressure monitoring devices
15.16.3. Intracranial pressure monitoring devices
15.17. Colombia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
15.17.1. Hospitals
15.17.2. Ambulatory surgical centers
15.17.3. Others
15.18. Argentina AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
15.18.1. Neurodegenerative disorders
15.18.2. Autoimmune diseases
15.18.3. Cancer and Tumors
15.18.4. Cardiovascular Diseases
15.19. Argentina AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
15.19.1. Blood Pressure monitoring devices
15.19.2. Pulmonary pressure monitoring devices
15.19.3. Intracranial pressure monitoring devices
15.20. Argentina AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
15.20.1. Hospitals
15.20.2. Ambulatory surgical centers
15.20.3. Others
15.21. Rest of South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications
15.21.1. Neurodegenerative disorders
15.21.2. Autoimmune diseases
15.21.3. Cancer and Tumors
15.21.4. Cardiovascular Diseases
15.22. Rest of South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products
15.22.1. Blood Pressure monitoring devices
15.22.2. Pulmonary pressure monitoring devices
15.22.3. Intracranial pressure monitoring devices
15.23. Rest of South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users
15.23.1. Hospitals
15.23.2. Ambulatory surgical centers
15.23.3. Others
15.24. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis
15.24.1. By Applications
15.24.2. By Products
15.24.3. By End-users
15.25. PEST Analysis
15.26. Key Trends
15.27. Key Developments
16. Company Profiles
16.1. Market Share Analysis, By Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players By price, presence, market share, Products, and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A By Regions, Investment and Products
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. Fibrocell Science, Inc
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. Astrom Biosciences
16.3.3. Dendreon Corporation
16.3.4. NeoStem, Inc
16.3.5. Brainstorm Cell therapeutics
16.3.6. Regeneus Ltd
16.3.7. Genzyme Corporation
16.3.8. Antria
16.3.9. Bioheart
16.3.10. Cytori Therapeutics
16.3.11. Genesis Biopharma
16.3.12. Opexa Therapeutics
16.3.13. Orgenesis
16.3.14. Regenexx
16.3.15. Tengion
16.3.16. Sanofi
16.3.17. Mesoblast Ltd
16.3.18. Virxsys
16.3.19. StemGeneXamong
16.3.20. Vericel Corporation
16.3.21. Med Cell Europe AG
16.3.22. IovanceBiotherapeutics Inc